Checkpoint Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Checkpoint Therapeutics stock had an average target of $4.33, with a low estimate of $4.10 and a high estimate of $4.80.

Price Target: $4.33 (+1.64%)

Analyst Consensus: Buy

Price Target

Target	Low	Average	Median	High
Price	$4.10	$4.33	n/a	$4.80
Change	-3.76%	+1.64%	n/a	+12.68%

Analyst Ratings

The average analyst rating for Checkpoint Therapeutics stock from 3 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available

Rating	Oct 2026
Strong Buy	n/a
Buy	n/a
Hold	n/a
Sell	n/a
Strong Sell	n/a
Total	n/a

Financial Forecast

Revenue This Year

41.94M

from 41.00K

102,182.93%

from 41.00K

Revenue Next Year

189.43M

from 41.94M

351.71%

from 41.94M

EPS This Year

-0.18

from -1.42

EPS Next Year

1.15

from -0.18

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.07M	268.00K	192.00K	103.00K	41.00K	41.94M	189.43M
Revenue Growth	-37.41%	-74.93%	-28.36%	-46.35%	-60.19%	102,182.93%	351.71%
EPS	-4.13	-6.70	-6.09	-1.87	-1.42	-0.18	1.15
Forward PE	-	-	-	-	-	-	3.70
No. Analysts	-	-	-	-	-	4	3

Revenue Forecast

Revenue	2025	2026
High	76.5M	195.0M
Avg	41.9M	189.4M
Low	9.2M	182.0M

Revenue Growth

Revenue Growth	2025	2026
High	186,409.8%	365.0%
Avg	102,182.9%	351.7%
Low	22,368.3%	334.0%

EPS Forecast

EPS	2025	2026
High	0.45	1.19
Avg	-0.18	1.15
Low	-0.76	1.11

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-